Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
ACS Nano|August 18, 2021
Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional AddictionChen-Song Huang, Qiong-Cong Xu, Chunlei Dai, et al.Heliyon|September 12, 2024
Turning to immunosuppressive tumors: Deciphering the immunosenescence-related microenvironment and prognostic characteristics in pancreatic cancer, in which GLUT1 contributes to gemcitabine resistanceSi-Yuan Lu, Qiong-Cong Xu, De-Liang Fang, et al.Cancer Letters|September 22, 2025
Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcinomaSi-Yuan Lu, De-Liang Fang, Zi-Yi Zhao, et al.The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|March 7, 2025
Comparison of Short-Term Outcomes Between Robotic-Assisted and Open Pancreatoduodenectomy: A Retrospective Cohort Study With Inverse Probability of Treatment Weighting (IPTW) AnalysisXi-Tai Huang, Jin-Zhao Xie, Jian-Peng Cai, et al.Zhonghua Yi Xue Za Zhi|November 19, 2011
[Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]Wen-Zhe Fan, Jian-Yong Yang, Ming-de Lü, et al.Cell Proliferation|May 22, 2024
ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing mannerQi Liu, Chen-Song Huang, Siyun Chen, et al.Neuroscience Letters|November 1, 2015
VEGF-mediated NF-κB activation protects PC12 cells from damage induced by hypoxiaShi-Jing Mo, Jun Hong, Xu Chen, et al.Cancer Science|August 7, 2019
EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β-catenin at Ser552Xiao-Xu Zhu, Jian-Hui Li, Jian-Peng Cai, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 27, 2025
Positive Feedback Loop of Histone Lactylation-Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcinoma Gemcitabine ResistanceXi-Tai Huang, Jiao Chen, En-Liang Zhu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2020
Targeting Super-Enhancers via Nanoparticle-Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal AdenocarcinomaChen-Song Huang, Xinru You, Chunlei Dai, et al.Pageof 12